Venturing Beyond The Magic Kingdom: Former Disney CFO, Fortune 500 Veteran Takes Reins At Psychedelics Company
Portfolio Pulse from Lara Goldstein
Richard Nanula, former CFO of The Walt Disney Corporation and Amgen Inc., has taken over as CEO of Lucy Scientific Discovery. He succeeds Chris McElvany, who will remain involved with the company as a consultant. Lucy Scientific Discovery is involved in the development, sale, delivery, and manufacture of pharmaceutical-grade Active Pharmaceutical Ingredients used in controlled substances and their raw material precursors.
July 14, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amgen Inc.'s former CFO Richard Nanula's appointment as CEO of Lucy Scientific Discovery is unlikely to have a significant impact on Amgen's stock.
Richard Nanula's appointment as CEO of Lucy Scientific Discovery is unlikely to have a significant impact on Amgen's stock as he is no longer associated with the company.
CONFIDENCE 90
IMPORTANCE 10
RELEVANCE 20
NEUTRAL IMPACT
The Walt Disney Corporation's former CFO Richard Nanula's appointment as CEO of Lucy Scientific Discovery is unlikely to have a significant impact on Disney's stock.
Richard Nanula's appointment as CEO of Lucy Scientific Discovery is unlikely to have a significant impact on Disney's stock as he is no longer associated with the company.
CONFIDENCE 90
IMPORTANCE 10
RELEVANCE 20
POSITIVE IMPACT
Richard Nanula's appointment as CEO could bring significant strategic focus and leadership to Lucy Scientific Discovery.
The appointment of a former Fortune 500 CFO as CEO could bring significant strategic focus and leadership to the company, potentially driving its stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100